Expression of prognostic factors (EGFR, ER) by immunohistochemical staining method in male breast cancer.

Hyuncheol Chung, D. L. Kim, E. H. Koh, J. H. Kim, J. K. Roh, J. S. Min, K. S. Lee, W. I. Yang, B. S. Kim, K. B. Lee

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Twelve male patients with operable breast cancer were evaluated for the expression of prognostic factors by immunohistochemical staining assay. Seven patients were stage I & II, and five patients were stage III. Axillary lymph node positivity was 42%. Nine patients were nuclear grade I, three were nuclear grade II, and none were nuclear grade III. The expression rate of EGFR (epidermal growth factor receptor), ER (estrogen receptor) were 8.3%, 70.0% respectively. This limited data suggest better tumor behavior in male than in female breast cancer. Adjuvant treatment should be considered in male breast cancer just as in females, based on axillary lymph node and ER states.

Original languageEnglish
Pages (from-to)126-130
Number of pages5
JournalYonsei medical journal
Volume32
Issue number2
DOIs
Publication statusPublished - 1991 Jan 1

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Chung, H., Kim, D. L., Koh, E. H., Kim, J. H., Roh, J. K., Min, J. S., Lee, K. S., Yang, W. I., Kim, B. S., & Lee, K. B. (1991). Expression of prognostic factors (EGFR, ER) by immunohistochemical staining method in male breast cancer. Yonsei medical journal, 32(2), 126-130. https://doi.org/10.3349/ymj.1991.32.2.126